 FRAMINGHAM, Mass., Dec. 11, 2020 GLOBE NEWSWIRE -- Arch Therapeutics, Inc. OTCQB: ARTH Arch or the Company, developer of novel self-assembling wound care and biosurgical devices, announced today that it will be presenting at the 13th annual LD Micro Main Event investor conference. This investor conference will take place December 14-15, 2020, on the Sequire Virtual Events platform. 